Sirona Biochem Corp. (SRBCF)
0.0051
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Sirona Biochem Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| July 31, 2024 | -0.9582 |
| April 30, 2024 | -0.8926 |
| January 31, 2024 | -0.8405 |
| October 31, 2023 | -0.8693 |
| July 31, 2023 | -1.253 |
| April 30, 2023 | -1.905 |
| January 31, 2023 | -1.165 |
| October 31, 2022 | 2.191 |
| July 31, 2022 | 0.5723 |
| April 30, 2022 | 0.7023 |
| January 31, 2022 | -1.613 |
| October 31, 2021 | -9.101 |
| July 31, 2021 | -1.448 |
| April 30, 2021 | -3.352 |
| January 31, 2021 | -3.083 |
| October 31, 2020 | 26.24 |
| July 31, 2020 | 1.972 |
| April 30, 2020 | 0.6736 |
| January 31, 2020 | 0.4988 |
| October 31, 2019 | 0.7073 |
| July 31, 2019 | 0.6702 |
| April 30, 2019 | -1.446 |
| January 31, 2019 | -0.8735 |
| October 31, 2018 | -1.094 |
| July 31, 2018 | -1.266 |
| Date | Value |
|---|---|
| April 30, 2018 | -1.094 |
| January 31, 2018 | -1.317 |
| October 31, 2017 | -1.312 |
| July 31, 2017 | -15.65 |
| April 30, 2017 | 4.709 |
| January 31, 2017 | 1.205 |
| October 31, 2016 | 0.6197 |
| July 31, 2016 | 0.4756 |
| April 30, 2016 | 0.2899 |
| January 31, 2016 | 0.3886 |
| October 31, 2015 | 0.595 |
| July 31, 2015 | 0.784 |
| April 30, 2015 | 0.8677 |
| January 31, 2015 | 1.299 |
| October 31, 2014 | 0.3762 |
| July 31, 2014 | 0.3467 |
| April 30, 2014 | 0.1978 |
| January 31, 2014 | 0.236 |
| October 31, 2013 | 0.2302 |
| July 31, 2013 | 0.2937 |
| April 30, 2013 | 0.2789 |
| January 31, 2013 | 0.2991 |
| October 31, 2012 | 0.0547 |
| July 31, 2012 | 0.0194 |
| April 30, 2012 | 0.0199 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Xenon Pharmaceuticals, Inc. | 0.0052 |
| Psyence Biomedical Ltd. | -- |
| Aurinia Pharmaceuticals, Inc. | 0.1043 |
| enGene Therapeutics, Inc. | 0.1307 |
| Medicus Pharma Ltd. | -12.27 |